Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
29.33
+0.63 (2.20%)
Dec 5, 2025, 1:16 PM EST - Market open
Rapport Therapeutics Market Cap
Rapport Therapeutics has a market cap or net worth of $1.4 billion as of December 5, 2025. Its market cap has increased by 79.18% in one year.
Market Cap
1.40B
Enterprise Value
866.72M
1-Year Change
79.18%
Ranking
Category
Stock Price
$29.33
Market Cap Chart
Since the IPO on June 7, 2024, Rapport Therapeutics's market cap has increased from $601.40M to $1.40B, an increase of 132.44%. That is a compound annual growth rate of 75.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 1.37B | 110.81% |
| Dec 31, 2024 | 648.87M | 7.89% |
| Jun 7, 2024 | 601.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 917.77B |
| Johnson & Johnson | 491.28B |
| AbbVie | 406.14B |
| UnitedHealth Group | 306.18B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 251.48B |
| Abbott Laboratories | 217.20B |